Search Application

Drugs
HSE Application ID
HTA Number
Drug
Brand
Indication
Application
Status
Status Date
HSE100009
25001
Maralixibat
Livmarli®
For the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) 2 months of age and older.
NCPE Assessment Completed
30/03/2026